HealthNotableReported
5.2
AstraZeneca's Imfinzi Combo Gets FDA Priority Review for Bladder Cancer
Dagens IndustriLO·US · GB·3 days ago
A new blood test demonstrates potential for early detection of pancreatic cancer, a disease often diagnosed late. The test's sensitivity and specificity remain unquantified in this report, and clinical validation is pending. If confirmed, it could improve survival rates by enabling earlier intervention.